All Stories

Want a piece of Lilly's $27B US manufacturing investmen...

Eli Lilly has established an online portal to accept submissions for possible lo...

Leo Pharma, awaiting FDA approval decision, finds derma...

A new survey commissioned by Leo Pharma confirms that there’s plenty of room in ...

Novo counters compounders with direct access channel fo...

The move follows a similar price cut by Eli Lilly as both GLP-1 drugmakers attem...

Lilly’s 1st DTC Ebglyss campaign highlights eczema’s ef...

After scoring a long-awaited FDA approval last fall, Eli Lilly has launched a co...

As Xarelto's decline picks up speed, Bayer doesn't expe...

After Bayer's blood thinner Xarelto saw a sales decline of 600 million euros ($6...

CordenPharma to build €500M Swiss peptide plant, genera...

CDMO CordenPharma plans to spend half of its €1 billion strategic peptide invest...

Want a piece of Lilly’s $27B US manufacturing investmen...

Eli Lilly has established an online portal to accept submissions for possible lo...

Regulatory tracker: Roche's Gazyva under FDA review in ...

In this tracker, Fierce Pharma is recording the regulatory progress of in-market...

FDA blasts Edenbridge over 'misleading' exhibit booth p...

The FDA has sent its first untitled letter of 2025, hitting Edenbridge Pharmaceu...

After peptide expansion, Axplora hits the gas to boost ...

German CDMO Axplora hit the gas at its Le Mans, France, facility with the additi...

Granules slammed in FDA warning letter detailing discar...

In a warning letter dated Feb. 26, the FDA upbraided Granules over a slate of pr...

UPDATE: Bristol Myers' cost-savings drive claims anothe...

Beginning in late May, BMS will lay off 223 workers in Lawrenceville, New Jersey...

UPDATED: Bristol Myers' cost-savings drive claims anoth...

Beginning in late May, BMS will lay off 223 workers in Lawrenceville, New Jersey...

Want HCPs’ attention? Here’s what drug marketing messag...

ZoomRx has dug into its data to see what messages resonate with healthcare profe...

Gilead sets aside $200M for potential settlement over H...

Gilead set aside approximately $200 million for a potential resolution of an eig...

Arbutus, Genevant expand COVID patent feud with Moderna...

The companies claim that Moderna stepped on their lipid nanoparticle technology ...

As Gardasil underwhelms, Merck lights up landmarks in C...

Merck & Co. is leveraging the March 4 International HPV Awareness Day for a mark...

Glenmark issues another recall, this time for nearly 1....

Glenmark Pharma, an India-based drug manufacturer that has been the focal point ...

Tech and service specialist Cytiva charts 85 layoffs at...

Cytiva will lay off 85 employees from its facility in Westborough, Massachusetts...

Regulatory tracker: Eisai's Alzheimer's drug Leqembi re...

In this tracker, Fierce Pharma is recording the regulatory progress of in-market...

Pfizer could shift overseas production to US if Trump's...

Pfizer’s local manufacturing setup is already well positioned in the United Stat...

AstraZeneca, Daiichi unblind Enhertu study early as sta...

AstraZeneca and Daiichi Sankyo's Enhertu has become the first HER2-directed drug...

Roche gains label expansion for heart attack medicine T...

Over nearly the last three decades, Genentech has had the lone medicine on the m...

Takeda rains 100 toy zebras down on Boston Celtics fans...

Takeda made it rain zebras at a Boston Celtics game Friday. The stunt saw 100 to...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.